P53-mutated tumors are classically associated with more aggressive tumor histological types and a pejorative prognosis, such as high-grade endometrioid carcinomas, serous carcinomas and carcinosarcomas [4]. This evidence concerns the gene TP53 and endometrioid adenocarcinoma.